BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guarner-Lans V, Ramírez-Higuera A, Rubio-Ruiz ME, Castrejón-Téllez V, Soto ME, Pérez-Torres I. Early Programming of Adult Systemic Essential Hypertension. Int J Mol Sci 2020;21:E1203. [PMID: 32054074 DOI: 10.3390/ijms21041203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Cao L, Tan Y, Zheng Y, Gui Y. N-acetylcysteine protects neonatal mice from ventricular hypertrophy induced by maternal obesity in a sex-specific manner. Biomed Pharmacother 2021;133:110989. [PMID: 33378994 DOI: 10.1016/j.biopha.2020.110989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lerman LO. Cell-based regenerative medicine for renovascular disease. Trends Mol Med 2021:S1471-4914(21)00149-0. [PMID: 34183258 DOI: 10.1016/j.molmed.2021.06.004] [Reference Citation Analysis]
3 Ordóñez-Díaz MD, Gil-Campos M, Flores-Rojas K, Muñoz-Villanueva MC, Mesa MD, de la Torre-Aguilar MJ, Gil Á, Pérez-Navero JL. Impaired Antioxidant Defence Status Is Associated With Metabolic-Inflammatory Risk Factors in Preterm Children With Extrauterine Growth Restriction: The BIORICA Cohort Study. Front Nutr 2021;8:793862. [PMID: 34993223 DOI: 10.3389/fnut.2021.793862] [Reference Citation Analysis]
4 Padmanabhan V, Song W, Puttabyatappa M. Praegnatio Perturbatio-Impact of Endocrine-Disrupting Chemicals. Endocr Rev 2021;42:295-353. [PMID: 33388776 DOI: 10.1210/endrev/bnaa035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pérez-Torres I, Soto ME, Castrejón-Tellez V, Rubio-Ruiz ME, Manzano Pech L, Guarner-Lans V. Oxidative, Reductive, and Nitrosative Stress Effects on Epigenetics and on Posttranslational Modification of Enzymes in Cardiometabolic Diseases. Oxid Med Cell Longev 2020;2020:8819719. [PMID: 33204398 DOI: 10.1155/2020/8819719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kraushaar LE, Bauer P. Dismantling Anti-Ageing Medicine: Why Age-Relatedness of Cardiovascular Disease is Proof of Robustness Rather Than of Ageing-Associated Vulnerability. Heart Lung Circ 2021:S1443-9506(21)00585-0. [PMID: 34244067 DOI: 10.1016/j.hlc.2021.05.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Evans LE, Taylor JL, Smith CJ, Pritchard HAT, Greenstein AS, Allan SM. Cardiovascular co-morbidities, inflammation and cerebral small vessel disease. Cardiovasc Res 2021:cvab284. [PMID: 34499123 DOI: 10.1093/cvr/cvab284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Brandes RP, Gilsbach R. Is It in the EPIgenome?: Epigenetics Marks at Birth Are Associated With Arterial Stiffness in Children. Hypertension 2021;78:801-3. [PMID: 34379434 DOI: 10.1161/HYPERTENSIONAHA.121.17777] [Reference Citation Analysis]
9 Tain Y, Hsu C. Oxidative Stress-Induced Hypertension of Developmental Origins: Preventive Aspects of Antioxidant Therapy. Antioxidants 2022;11:511. [DOI: 10.3390/antiox11030511] [Reference Citation Analysis]
10 Shi J, Yang Y, Cheng A, Xu G, He F. Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol 2020;319:H613-31. [PMID: 32762559 DOI: 10.1152/ajpheart.00220.2020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]